Phenom Named Strategic Leader in Fosway 9-Grid™ for Talent Acquisition 2024 for Fourth Consecutive Year
Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. Fosway identifies Strategic Leaders as companies that provide a rich suite of capability across a broad scope of features and have the sophistication to consistently meet the needs of complex enterprise-scale customers. Strategic Leaders are also recognised by Fosway for having strong market performance and customer advocacy; as a result, they are frequently selected by such organisations and consistently meet their needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240530551981/en/
Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. (Graphic: Business Wire)
The European job market is undergoing a significant transformation. Challenges such as talent shortages and technological disruptions are actively shaping the dynamics of recruitment practices. To navigate this, talent acquisition leaders, sourcers, talent marketers, recruitment events managers, and recruiters must adopt a multifaceted approach that encompasses building alliances, appropriately leveraging and consolidating technology, personalising candidate engagement, maximising utilisation of artificial intelligence and automation, and embracing data insights.
“The TA industry faces many challenges due to a fragmented tech stack, and companies often struggle to streamline their recruitment processes and engage candidates effectively,” said David Wilson, CEO and founder of Fosway Group. “Phenom’s Intelligent Talent Experience platform aims to deliver an effective, data-driven, personalised enterprise solution to these issues. Their continued innovation and customer outcomes are reflected in their position as a Strategic Leader for a fourth successive year.”
The Most Productive, Efficient Organisations Will Define the Decade Ahead
More than 600 global, diverse enterprises use Phenom’s automations, intelligence, and experience to achieve measurable, defensible results, including the ability to:
- Secure 5x more job seekers per month
- Increase chatbot-generated leads by 93%
- Improve application conversion with 85% completion rates
- Accelerate interview scheduling with 88% booked within 24 hours
- Cut 65 days off time to hire
- Save thousands of dollars per hire and reduce dependency on third-parties
“Phenom's fourth consecutive year being recognised as a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition reaffirms our commitment to innovation, customer impact, and advocacy,” said John Harrington, Senior Director, Product Marketing at Phenom. “Securing the highest positioning in performance and potential is a testament to our 13+ years in the industry and reflects our ability to partner with global organisations across all industries to address their unique challenges and exceed their goals.”
Leading the Way in Generative AI Adoption and Impact in HR
The advent of generative AI in the past year afforded Phenom a significant opportunity to address the challenges being experienced by its customers with immediate solutions that drive efficiency and productivity outcomes. Since its introduction in 2023, Phenom X+ Generative AI in Phenom’s Intelligent Talent Experience platform has been adopted by over 600 customers, supporting over 60 use cases, and saving HR teams 37,000 hours in the process. Top X+ generative AI use cases and examples of time savings include:
- Email generation, saving Talent CRM users over 6 minutes per email
- Generation of profile summaries, affording 15 hours back to talent acquisition teams each week
- Development of SMS and email campaigns, leading to 35% higher response rates from candidates
Unleashing a Massive Wave of HR Tech Innovation
Phenom continues to innovate by introducing new functionality and capabilities intended to address the top challenges being experienced by talent practitioners today.
2024 Phenom platform innovation highlights include:
- Talent Experience Engine: transforms talent marketers into strategists by leveraging large datasets to create personalised, on-brand campaigns. It enhances efficiency by unifying persona and journey data, enabling content creation, segment identification, personalised journeys, and automated outreach. This comprehensive set of tools optimises engagement and conversion for candidates, employees, and alumni.
- X+ Source: optimises sourcing by segmenting talent pools and creating personalised journeys to attract best-fit candidates. Simply request candidates for a specific role and location, and X+ Source finds the best-fit talent, provides recommendations, summarises key details, and conducts automatic outreach to establish initial contact.
- X+ Workforce Intelligence: connects data from employees, management, HR teams, candidates, and recruiters to provide real-time talent insights for proactive retention and growth. HR teams and managers can identify skills gaps, create personalised development plans, and designate successors based on data to find ideal candidates.
- Talent Marketer Experience: empowers talent marketers to craft personalised content, design campaigns, segment talent, and engage effectively using AI and automation. X+ Agents guide marketers through tasks, enhancing engagement throughout the talent lifecycle via a single, unified platform.
- Talent Leader Experience: provides recruitment managers with organisation-wide insights and individual performance data, including requisition and candidate interaction metrics. X+ Agents offer tailored action plans based on hiring type, enhancing team efficiency and effectiveness.
- X+ Screening: enables fast, intelligent hiring decisions by offering comprehensive insights based on recorded answers, situational judgment questions, and call simulations for all job types.
- Structured Interviews: streamlines interview processes with automated note-taking, question management, and real-time transcription. It enables hiring teams to focus on meaningful candidate interactions while reducing human error and leveraging AI for confident hiring decisions through organised and analysed data.
- Contingent Talent Hiring: helps top brands attract contractors effortlessly via Phenom. Companies can now seamlessly discover and hire temporary workers, with integrated support for Vendor Management Systems and payroll providers for smooth onboarding.
- Events Pro: streamlines event creation to easily target demographics through email, SMS, and registration forms. Personalised virtual event lobbies allow talent to review content, visit booths, and receive automatic event summaries via email.
- Phenom Assessments: have expanded the existing behavioral and language assessments to include motivation and interest assessments to guide early talent to the right jobs.
- X+ Fit Score: enables talent acquisition professionals to extend the typical criteria used to formulate fit scores, or customise the scores in the context of the role.
Companies across EMEA are successfully adopting Phenom’s Intelligent Talent Experience platform to help candidates find and choose the right job faster, employees develop their skills and evolve, recruiters become wildly productive, talent marketers engage with extreme efficiency, talent leaders optimise hiring processes, managers build stronger-performing teams, HR align employee development with company goals, and HRIS easily integrate existing HR tech to create a holistic infrastructure.
On June 6, Phenom is demonstrating its massive wave of recent platform innovations during its HR Innovation Showcase. Register here for the streaming event and see how Phenom continues to innovate, earning its position as a Strategic Leader for the fourth consecutive year.
About the Fosway 9-Grid™
Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at www.fosway.com.
About Phenom
Phenom has a purpose of helping a billion people find the right work. Through AI-powered talent experiences, employers use Phenom to hire employees faster, develop them to their full potential, and retain them longer. The Phenom Intelligent Talent Experience platform seamlessly connects candidates, employees, recruiters, talent marketers, talent leaders, hiring managers, HR and HRIS — empowering diverse and global enterprises with innovative products including Phenom X+ Generative AI, Career Site, Chatbot, CMS, Talent CRM, One-Way Interviews, Automated Interview Scheduling, Interview Intelligence, Talent Experience Engine, Campaigns, University Recruiting, Contingent Talent Hiring, Talent Marketplace, Workforce Intelligence, Career Pathing, Gigs, Mentoring, and Referrals.
Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (4 consecutive years), Deloitte Technology's Fast 500 (4 consecutive years), five Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in AI for Business Impact,’ Business Intelligence Group's Artificial Intelligence Excellence Awards (3 consecutive years), and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).
Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.
For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, Twitter, Facebook, YouTube and Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240530551981/en/
Contact information
Media:
Jennifer Lyons
Phenom
267-379-5066
jennifer.lyons@phenom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Shines a Light on Inequalities and Unmet Needs in Care as Part of Its Commitment to People With Cardiovascular Disease31.8.2024 18:00:00 EEST | Press release
Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care, by shining a light on inequalities in treatment and outcomes experienced by various patient groups. The announcement follows the presentation of data from sub-analyses of the SANTORINI observational study and ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients with nonvalvular Atrial Fibrillation) study programme, at the European Society of Cardiology (ESC) Congress 2024. Gender inequalities in CV disease treatment and LDL-C goal attainment Raised low-density lipoprotein cholesterol (LDL-C) is a key modifiable contributor to risk of cardiovascular major events. It has been shown that for every 1 mmol/L reduction in LDL-C, there is a 22% reduction in major cardiovascular events after 1 year.7,8 Female patients in Europe who are at high or very high CV risk were undertreated and less achieved guideline-recomm
Suzano completes purchase of 15% stake in Lenzing AG31.8.2024 01:40:00 EEST | Press release
Suzano, the world's largest pulp producer, today announces the completion of its acquisition of a 15% stake in Lenzing AG, the Vienna-listed leading global supplier of sustainable premium cellulosic fibres for the textile and non-wovens industry, from B&C Group. As announced in June this year, the transaction value is EUR 230 million (or EUR 39.70 per share). The agreement was subject to regulatory approval, which was granted without restrictions. The long-term partnership between Suzano and B&C Group establishes that Suzano has the right to hold two seats on Lenzing’s Board and the option to acquire an additional 15% stake from B&C Group until the end of 2028. Following the sale of the 15% stake, B&C Group now holds 37.25% of Lenzing’s share capital. Lenzing is a leading global supplier of premium wood-based cellulosic fibers (lyocell, modal, and viscose) for the production of clothing, home textiles, hygiene products, and non-woven materials. Beto Abreu, CEO of Suzano, said: “Lenzing
Ant International Collaborates with Brazilian Partners to Drive Financial Inclusion with Innovative Credit Tech Solutions30.8.2024 21:46:00 EEST | Press release
Ant International, a digital payment and financial technology leader, today announced its strategic initiative to provide AI-driven credit technology solutions designed to empower local partners and advance financial inclusions in Brazil. As a major milestone, Ant International has formed a strategic partnership with Dock, a leader in payments and banking technology in Latin America. This collaboration aims to enhance the credit management capability and infrastructure efficiency for Dock’s clients, which include financial institutions, retailers, fintech start-ups, etc. The shared vision is to make credit services more inclusive for market segments that are currently insufficiently served, such as micro, small and medium-sized enterprises (MSMEs). In the initial phase of the collaboration, Ant International’s AI-driven credit tech solutions, including an automated and intelligent risk management engine, will be explored for integration into Dock One platform. This initiative aims to s
Wipro Appoints Srikumar Rao as Global Head of Its Engineering Edge Business Line30.8.2024 17:20:00 EEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced the appointment of Srikumar Rao as Global Head of its Engineering Edge Business Line, effective from October 5, 2024. Srikumar succeeds Harmeet Chauhan, who is stepping down to pursue opportunities outside the organization. Srikumar will report to Srini Pallia. Srikumar has been with Wipro for 26 years and has grown with the organization, serving in various leadership roles. He was most recently the Chief Operating Officer (COO) of Wipro Engineering Edge (WEE) and Global Practice Head of Embedded Systems. His work has spanned several markets, selling and delivering specialized Engineering, Research, and Development (ER&D) services to Software & Internet, Semiconductor, Automotive, Manufacturing, and Communications clients. In his new role, Srikumar will continue to scale and strengthen Wipro’s engineering prowess. He will also be responsible for defining the vision
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress30.8.2024 13:00:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). The data were presented today in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024, taking place August 30-September 2 in London, United Kingdom. Results from the HELIOS-B study were also simultaneously published in TheNew England Journal of Medicine. As previously reported, the HELIOS-B study met all 10 of its primary and secondary endpoints, across both the overall and monotherapy populations, with statistical significance. Enrolled patients were predominantly New York Heart Association (NYHA) Class I or II with wild-type disease and had been diagnosed by non-invasive methods, with substantial concurrent treatment with available standard of care treatments such as tafamidis and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom